In sum, these present findings indicated that the ameliorative effects of kirenol on the inflammation of LPS-induced ALI mice through inhibiting the proinflammatory NF-κB pathway and promoting the AMPK2-/Nrf2-mediated HO-1/AOE pathway. Here, NFE2L2 is linked to acute respiratory distress syndrome.